266 related articles for article (PubMed ID: 34070435)
1. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.
Liu X; Lillywhite J; Zhu W; Huang Z; Clark AM; Gosstola N; Maguire CT; Dykxhoorn D; Chen ZY; Yang J
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070435
[TBL] [Abstract][Full Text] [Related]
2. Generation of the induced pluripotent stem cell line SFMUi001-A from a patient with usher syndrome type 2 caused by biallelic variants in the USH2A gene.
Qiu S; Zhang X; Zhang L; Liu Z; Wang L; Jin ZB; Xiao P
Stem Cell Res; 2023 Jun; 69():103101. PubMed ID: 37126974
[TBL] [Abstract][Full Text] [Related]
3. Establishment of iPS cell line (KLRMMEi002-A) by reprogramming peripheral blood mononuclear cells from a patient with USH2A-associated Usher syndrome.
Liang L; Xue Y; Su C; Wang J; Chen L; Su T; Ke J; Xie L; Cui Z; Yu Q; Chan HF; Zhong J; Guo Y; Chen J
Stem Cell Res; 2022 Apr; 60():102699. PubMed ID: 35152177
[TBL] [Abstract][Full Text] [Related]
4. Genome Editing in Patient iPSCs Corrects the Most Prevalent
Sanjurjo-Soriano C; Erkilic N; Baux D; Mamaeva D; Hamel CP; Meunier I; Roux AF; Kalatzis V
Mol Ther Methods Clin Dev; 2020 Jun; 17():156-173. PubMed ID: 31909088
[TBL] [Abstract][Full Text] [Related]
5.
Ordoñez-Labastida V; Chacon-Camacho OF; Lopez-Rodriguez VR; Zenteno JC
Mol Vis; 2023; 29():31-38. PubMed ID: 37287646
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
Pendse ND; Lamas V; Pawlyk BS; Maeder ML; Chen ZY; Pierce EA; Liu Q
Adv Exp Med Biol; 2019; 1185():91-96. PubMed ID: 31884594
[TBL] [Abstract][Full Text] [Related]
7. The effect of the common c.2299delG mutation in USH2A on RNA splicing.
Lenassi E; Saihan Z; Bitner-Glindzicz M; Webster AR
Exp Eye Res; 2014 May; 122():9-12. PubMed ID: 24607488
[TBL] [Abstract][Full Text] [Related]
8. Generation of two human induced pluripotent stem cell lines from patients with biallelic USH2A variants.
Zhu T; Wu S; Sun Z; Wei X; Han X; Zou X; Sui R
Stem Cell Res; 2021 Aug; 55():102502. PubMed ID: 34419747
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II.
Yan D; Ouyang X; Patterson DM; Du LL; Jacobson SG; Liu XZ
J Hum Genet; 2009 Dec; 54(12):732-8. PubMed ID: 19881469
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.
Reiners J; Nagel-Wolfrum K; Jürgens K; Märker T; Wolfrum U
Exp Eye Res; 2006 Jul; 83(1):97-119. PubMed ID: 16545802
[TBL] [Abstract][Full Text] [Related]
11. USH2A Gene Editing Using the CRISPR System.
Fuster-García C; García-García G; González-Romero E; Jaijo T; Sequedo MD; Ayuso C; Vázquez-Manrique RP; Millán JM; Aller E
Mol Ther Nucleic Acids; 2017 Sep; 8():529-541. PubMed ID: 28918053
[TBL] [Abstract][Full Text] [Related]
12.
Zhu T; Chen DF; Wang L; Wu S; Wei X; Li H; Jin ZB; Sui R
Br J Ophthalmol; 2021 May; 105(5):694-703. PubMed ID: 32675063
[TBL] [Abstract][Full Text] [Related]
13. Natural history of Usher type 2 with the c.2299delG mutation of
Meunier A; Zanlonghi X; Roux AF; Fils JF; Caspers L; Migeotte I; Abramowicz M; Meunier I
Ophthalmic Genet; 2022 Aug; 43(4):470-475. PubMed ID: 35345973
[TBL] [Abstract][Full Text] [Related]
14. Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A).
Iannaccone A; Brewer CC; Cheng P; Duncan JL; Maguire MG; Audo I; Ayala AR; Bernstein PS; Bidelman GM; Cheetham JK; Doty RL; Durham TA; Hufnagel RB; Myers MH; Stingl K; Zein WM;
Am J Med Genet A; 2021 Dec; 185(12):3717-3727. PubMed ID: 34331386
[TBL] [Abstract][Full Text] [Related]
15. Mutation screening of the USH2A gene reveals two novel pathogenic variants in Chinese patients causing simplex usher syndrome 2.
He C; Liu X; Zhong Z; Chen J
BMC Ophthalmol; 2020 Feb; 20(1):70. PubMed ID: 32093671
[TBL] [Abstract][Full Text] [Related]
16. [Mutational frequencies in usherin(USH2A gene) in 26 Colombian individuals with Usher syndrome type II].
López G; Gelvez NY; Tamayo M
Biomedica; 2011 Mar; 31(1):82-90. PubMed ID: 22159486
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of a human iPSC line (JUFMDOi007-A) from a patient with Usher syndrome due to mutation in USH2A.
Ukaji T; Takahashi-Shibata M; Arai D; Tsutsumi H; Tajima S; Akamatsu W; Matsumoto F; Ikeda K; Usami SI; Kamiya K
Stem Cell Res; 2023 Jun; 69():103100. PubMed ID: 37099934
[TBL] [Abstract][Full Text] [Related]
18. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
[TBL] [Abstract][Full Text] [Related]
19. Partial USH2A deletions contribute to Usher syndrome in Denmark.
Dad S; Rendtorff ND; Kann E; Albrechtsen A; Mehrjouy MM; Bak M; Tommerup N; Tranebjærg L; Rosenberg T; Jensen H; Møller LB
Eur J Hum Genet; 2015 Dec; 23(12):1646-51. PubMed ID: 25804404
[TBL] [Abstract][Full Text] [Related]
20. USH2A gene variants cause Keratoconus and Usher syndrome phenotypes in Pakistani families.
Ahmed AN; Tahir R; Khan N; Ahmad M; Dawood M; Basit A; Yasin M; Nowshid M; Marwan M; Sultan K; Saleha S
BMC Ophthalmol; 2021 Apr; 21(1):191. PubMed ID: 33926394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
